Similar Posts
GBPCHF Short Term Forecast Follow Up and Update
Traders Workshop – For Real Success – You Need To Learn From The Best! Complete Trading School by Vladimir Ribakov Hi Traders! GBPCHF short term forecast follow-up and update is here. On January 9th, 2025 I shared this “GBPCHF Technical Analysis And Short Term Forecast” post in our blog. In this post, let’s do a recap of…
Gold – 06.06.2024 – Orbex Forex Trading Blog
Gold – 06.06.2024 – Orbex Forex Trading Blog XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX;visibility:hidden”> Source link
Amsterdam’s Market Maker Optiver Joins London Metal Exchange
Executive Interview with Kathy Lian from BKTraders | iFX EXPO International 2025 Executive Interview with Kathy Lian from BKTraders | iFX EXPO International 2025 Executive Interview with Kathy Lian from BKTraders | iFX EXPO International 2025 Executive Interview with Kathy Lian from BKTraders | iFX EXPO International 2025 Executive Interview with Kathy Lian from BKTraders…
Sunset Market Commentary – Action Forex
Markets Markets are flying high following the “substantial progress” made during the first high-level US-Sino trade talks over the weekend. US Treasury Secretary Bessent, one of the attendees, shortly before the European open briefed what this meant in practice: a sharp reduction on both sides in import tariffs for 90 days. The US cut tariffs…
WTI Crude Oil: Elliott wave analysis and forecast for 19.12.25 – 26.12.25 | LiteFinance
2025.12.19 2025.12.19 WTI Crude Oil: Elliott Wave Analysis and Forecast for 19.12.25 – 26.12.25 Alex Geutahttps://www.litefinance.org/blog/authors/alex-geuta/ The article covers the following subjects: Major Takeaways Main scenario: Consider short positions from corrections below the level of 60.15 with a target of 50.50 – 45.00. A sell signal: the price holds below 60.15. Stop Loss: above 60.15,…
BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates
In February 2025, BiomX announced a series of financings with total gross proceeds of approximately $12 million to support completion of Phase 2b study of BX004; topline results anticipated in Q1 2026 Topline Phase 2 results for BX211 in diabetic foot osteomyelitis (DFO) expected by end of March 2025 Initiated exploration and analysis of real-world…
